Genus (CHIX:GNSL) Moat Score: 5/10 (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:GNSL Genus PLC CHIX:GNSL
72 GF Score
Price £21.18
GF Value £20.75
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Genus Moat Score?

Genus CHIX:GNSL +4.44% 72 Moat Score is 5 as of Jul. 15, 2026. GuruFocus rates CHIX:GNSL with a GF Score™ of 72/100 and a GF Value™ of £20.75 (Fairly Valued). The stock has 5 warning signs investors should review. Among 1,396 Biotechnology companies, Genus ranks better than 96.7% on this metric.

Genus has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

Genus has Narrow Moat: Genus PLC benefits from valuable intellectual property in animal genetics and a strong brand in its niche market. The company has moderate pricing power and customer loyalty, but faces competition and lacks significant regulatory barriers, resulting in a solid narrow moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Genus might have Narrow Moat - Solid narrow moat.

Genus  (CHIX:GNSl) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Genus Moat Score Related Terms

CHIX:GNSL vs VRTX, REGN, ALNY: Moat Score Comparison

For the Biotechnology subindustry, Genus's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genus Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genus's Moat Score distribution charts can be found below:

* The bar in red indicates where Genus's Moat Score falls into.


CHIX:GNSL
72GF Score
Genus PLC CHIX:GNSL
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
Genus (CHIX:GNSL) has a Moat Score of 5 as of Jul. 15, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Genus ranks #46 out of 1396 companies in the Biotechnology industry, placing it in the top 3.3%.
Is Genus' Moat Score too high?
Genus' current Moat Score is 5. The Biotechnology industry median Moat Score is 2.00. Genus' value of 5 is 150% above this industry median. Based on the distribution chart, Genus ranks #46 out of 1396 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Genus has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Genus' Moat Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Genus ranks #46 out of 1396 companies for Moat Score. This places Genus in the top 3% of its industry — outperforming the majority of peers. The industry median Moat Score is 2.00. Genus' value of 5 is 150% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,396 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genus's current Moat Score of 5 is 150% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genus's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genus stock overvalued right now?
Based on GuruFocus' analysis, Genus (CHIX:GNSL) is currently considered Fairly Valued. The stock's GF Value™ is £20.75, compared to a current price of £21.18 — trading 2.1% above its estimated fair value. The current Moat Score is 5 and 150% above the Biotechnology industry median of 2.00. Genus' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Genus (CHIX:GNSL), the current Moat Score is 5 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genus (CHIX:GNSL) Overvalued in 2026?

Based on GuruFocus' analysis, Genus stock appears to be overvalued. The current stock price of £21.18 is trading 2.1% above its estimated GF Value™ of £20.75. GuruFocus considers Genus to be Fairly Valued.

Key valuation signals for CHIX:GNSL:

  • Moat Score: 5
  • GF Value™: £20.75 vs. price of £21.18 (2.1% above fair value)
  • GF Score™: 72/100 with 5 warning signs
  • Industry Position: 150% above the Biotechnology median (#46 of 1396)

No single metric tells the full story. See the CHIX:GNSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genus Business Description

Address Matrix House, Basing View, Basingstoke, Hampshire, GBR, RG21 4FF
Genus PLC is an animal genetics company focused on improving cattle and pig populations to support sustainable food production. The company operates through two main business units: one providing bovine genetics mainly for dairy and beef cattle, and the other offering porcine genetics for pork production. Genus develops genetically superior breeding animals using scientific techniques. It generates revenue by selling genetics, including semen and embryos, as well as through related services under multi-year royalty agreements. The principal activities of each segment are: (a) Genus PIC porcine sales business, (b) Genus ABS: bovine sales business, and (c) Genus Research and Development: spending on research and development.
72GF Score

Get the complete analysis for CHIX:GNSL

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£21.18
Price
£20.75
GF Value